M. Bagot et al., ORAL DESENSITIZATION IN NICKEL ALLERGY INDUCES A DECREASE IN NICKEL-SPECIFIC T-CELLS, EJD. European journal of dermatology, 5(7), 1995, pp. 614-618
Nickel (Ni) is the most frequent cause of allergic contact dermatitis,
mainly in female patients. In animals, oral tolerance to Ni sensitiza
tion can be obtained by feeding with Ni sulfate (NiSO4). The aim of th
e present study was to compare the specific proliferative responses an
d frequencies of Ni-responding T cells from peripheral blood of patien
ts before and after a protocol of Ni ingestion. Ten patients with chro
nic disseminated eczema and patch test-proved contact allergy to Ni ga
ve informed consent for the study. All were non-pregnant female patien
ts between the ages of 21 and 40 years (mean 35 years). They ingested
22.4 mg NiSO4 (5 mg Ni) once a week for 8 weeks. All patients experien
ced an exacerbation of pruritus 12 to 24 hours after ingesting the fir
st capsules, resolving within 24 hours. Two patients had a major flare
-up of their eczema. Eight patients completed the whole study, and pre
sented a progressive improvement of their cutaneous lesions. In these
patients, the sums of individual epicutaneous test scores were decreas
ed after 8 weeks (p<0.02). Peripheral blood lymphocytes (PBL) were iso
lated and stored before and after Ni ingestion. Proliferation assays w
ere performed with 5 x 10(-5) mol/I NiSO4. Stimulation indexes were de
creased after 8 weeks when compared to preingestion PBL (p<0.02). A li
miting dilution assay was developed to quantify Ni-specific T cells fr
om peripheral blood. The frequencies of responding T-cells were decrea
sed after 8 weeks (1/49 061 to 1/2 517 920), when compared to preinges
tion PBL (1/14 547 to 1/128 682). Our results confirm that oral hypose
nsitization may decrease the degree of contact hypersensitivity as mea
sured by epicultaneous test and induce clinical improvement of cutaneo
us lesions. In addition, oral nickel intake can decrease Ni-specific p
roliferations and the numbers of Ni-responding T cells in peripheral b
lood. These data open a new area of investigation of the treatment of
Ni allergy.